Dermata Therapeutics is a biotechnology firm that focuses on advancements in the treatment of serious diseases treated by dermatologists.
Dermata Therapeutics has raised $2.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2026.
Dermata Therapeutics's investors include Silicon Valley Bank, Gerald Proehl, Kyri Van Hoose.
Dermata Therapeutics is headquartered in Encinitas, United States.
Dermata Therapeutics is a biotechnology firm that focuses on advancements in the treatment of serious diseases treated by dermatologists.
Dermata Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dermata Therapeutics — Funding & Investors." VCBacked, March 31, 2026, https://www.vcbacked.co/company/dermata-therapeutics. Accessed August 16, 2026.
VCBacked. (2026). Dermata Therapeutics — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/dermata-therapeutics
{{cite web |title=Dermata Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/dermata-therapeutics |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated